Key result
Hemodialysis and ultrafiltration improve clinical status and cut BNP ~80% in a cardiorenal HFpEF case.
Case Report (n=1)
No
Hemodialysis can be an effective therapeutic option for managing refractory congestion and uremia in patients with cardiorenal syndrome type 2 and HFpEF.
Answers are grounded in this paper and cite their sources.
Supports hemodialysis for refractory cardiorenal syndrome with HFpEF; hypothesis-generating and requires prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bah et al. (2024) conducted a case report in Cardiorenal Syndrome Type II with Heart Failure with Preserved Ejection Fraction (n=1). Hemodialysis and ultrafiltration was evaluated. Hemodialysis and ultrafiltration led to clinical improvement in an 84-year-old male with cardiorenal syndrome type 2 and HFpEF, including weight reduction and a decrease in BNP from 2000 to 400 ng/l.
Synapse has enriched 10 related papers. Consider them for comparative context: